Evidence map›Paper›PMID 28295287›Full record

ArticleInternational journal of cancer2017

Design considerations for identifying breast cancer risk factors in a population-based study in Africa.

Louise A Brinton, Baffour Awuah, Joe Nat Clegg-Lamptey, Beatrice Wiafe-Addai, Daniel Ansong, Kofi M Nyarko, Seth Wiafe, Joel Yarney, Richard Biritwum, Michelle Brotzman and 17 more

Abstract read
In one paragraph

Article in International journal of cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Contribution of Prediagnostic Host Factors to Shaping the Stromal Microenvironment of Breast Cancer among Sub-Saharan African Women.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Breast Cancer Risk in Women from Ghana Carrying Rare Germline Pathogenic Mutations.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Louise A BrintonDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.ORCID 0000-0003-3853-8562
Baffour AwuahKomfo Anoyke Teaching Hospital, Kumasi, Ghana.
Joe Nat Clegg-LampteyKorle Bu Teaching Hospital, Accra, Ghana.
Beatrice Wiafe-AddaiPeace and Love Hospital, Kumasi, Ghana.
Daniel AnsongKomfo Anoyke Teaching Hospital, Kumasi, Ghana.
Kofi M NyarkoUniversity of Ghana, Accra, Ghana.
Seth WiafePeace and Love Hospital, Kumasi, Ghana.
Joel YarneyKorle Bu Teaching Hospital, Accra, Ghana.
Richard BiritwumUniversity of Ghana, Accra, Ghana.
Michelle BrotzmanWestat, Inc, Rockville, MD.
Andrew A AdjeiUniversity of Ghana, Accra, Ghana.
Ernest AdjeiKomfo Anoyke Teaching Hospital, Kumasi, Ghana.
Francis AitpillahKomfo Anoyke Teaching Hospital, Kumasi, Ghana.
Lawrence EduseiKorle Bu Teaching Hospital, Accra, Ghana.
Florence DedeyKorle Bu Teaching Hospital, Accra, Ghana.
Sarah J NyanteDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
Joseph OppongKomfo Anoyke Teaching Hospital, Kumasi, Ghana.
Ernest Osei-BonsuKomfo Anoyke Teaching Hospital, Kumasi, Ghana.
Nicholas TitiloyeKomfo Anoyke Teaching Hospital, Kumasi, Ghana.
Verna VanderpuyeKorle Bu Teaching Hospital, Accra, Ghana.
Emma Brew AbaidooPeace and Love Hospital, Kumasi, Ghana.
Bernard ArhinKomfo Anoyke Teaching Hospital, Kumasi, Ghana.
Isaac BoakyeKomfo Anoyke Teaching Hospital, Kumasi, Ghana.
Margaret FrempongPeace and Love Hospital, Kumasi, Ghana.
Naomi Ohene OtiKorle Bu Teaching Hospital, Accra, Ghana.
Victoria OkyneUniversity of Ghana, Accra, Ghana.
Jonine D FigueroaDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.

Funding

Hormone-Related CancersZIACP010126 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI GIERACH, GRETCHEN · 2009 to 2025
$103.5M
Intramural NIH HHS ZIA CP010126
6 · The paper itself

Abstract

Although breast cancer is becoming more prevalent in Africa, few epidemiologic studies have been undertaken and appropriate methodologic approaches remain uncertain. We therefore conducted a population-based case-control study in Accra and Kumasi, Ghana, enrolling 2,202 women with lesions suspicious for breast cancer and 2,161 population controls. Biopsy tissue for cases prior to neoadjuvant therapy (if given), blood, saliva and fecal samples were sought for study subjects. Response rates, risk factor prevalences and odds ratios for established breast cancer risk factors were calculated. A total of 54.5% of the recruited cases were diagnosed with malignancies, 36.0% with benign conditions and 9.5% with indeterminate diagnoses. Response rates to interviews were 99.2% in cases and 91.9% in controls, with the vast majority of interviewed subjects providing saliva (97.9% in cases vs. 98.8% in controls) and blood (91.8% vs. 82.5%) samples; lower proportions (58.1% vs. 46.1%) provided fecal samples. While risk factor prevalences were unique as compared to women in other countries (e.g., less education, higher parity), cancer risk factors resembled patterns identified elsewhere (elevated risks associated with higher levels of education, familial histories of breast cancer, low parity and larger body sizes). Subjects with benign conditions were younger and exhibited higher socioeconomic profiles (e.g., higher education and lower parity) than those with malignancies, suggesting selective referral influences. While further defining breast cancer risk factors in Africa, this study showed that successful population-based interdisciplinary studies of cancer in Africa are possible but require close attention to diagnostic referral biases and standardized and documented approaches for high-quality data collection, including biospecimens.

Indexed as

AdolescentAdultBreast NeoplasmsCase-Control StudiesFemaleGhanaHumansLogistic ModelsMiddle AgedOdds RatioParityPopulation SurveillancePrevalenceResearch DesignRisk AssessmentRisk FactorsAfricabreast cancerepidemiologyrisk factors

Identifiers

PMID28295287
PMCPMC5926189

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.